U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. Smiths Medical Issues Urgent Medical Device Correction Informing Customers of a Potential Issue with Certain Sizes of Intubation ORAL/NASAL Endotracheal Tubes Being Smaller Than Expected
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

Smiths Medical Issues Urgent Medical Device Correction Informing Customers of a Potential Issue with Certain Sizes of Intubation ORAL/NASAL Endotracheal Tubes Being Smaller Than Expected

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Medical Devices
Reason for Announcement:
Recall Reason Description
Diameter of Device Smaller than Expected
Company Name:
Smiths Medical
Brand Name:
Brand Name(s)
Portex
Product Description:
Product Description
Intubation Oral/Nasal Endotracheal Tubes

Company Announcement

MINNEAPOLIS, MN. March 7, 2025 – Smiths Medical has issued an Urgent Medical Device Correction to notify affected global customers of a potential issue with the 2.0, 2.5, 3.0 and 3.5 mm sizes of Intubation ORAL/NASAL Endotracheal Tube products being smaller than expected.

If the diameter of the device is smaller than expected, it may potentially result in inadequate ventilation to the patient, post-insertion of the endotracheal tube. In such situations, the patient may experience hypoxia, underdose, and/or cardiopulmonary collapse which may lead to death. To date, Smiths Medical has received eight (8) reports of serious injury that are potentially related to this issue.

All impacted customers and distributors were sent a letter outlining the risk and providing specific steps to determine whether their devices are affected or not and what steps to follow if they have affected product in service. A copy of that letter as well as a list of affected products can be accessed on ICU Medical’s website here. Products were manufactured from 01 October 2019 to 03 October 2024 and distributed from 30 October 2019 to 16 December 2024.

For further inquiries, please contact Smiths Medical using the information provided below.

Smiths Medical Contact 

Contact Information 

Areas of Support 

Global Complaint Management

globalcomplaints@icumed.com
1-(866)-216-8806

To report adverse events or product complaints

Customer Service

Customerservice@icumed.com
1-(800)-259-5361

Questions about your product and/or replacement

Field Action Processing

smithsmedical6767@sedgwick.com
1-(877)-877-0317

Questions about this communication

The U.S. Food and Drug Administration (FDA) has been notified of this action.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.


Company Contact Information

Consumers:
Customer Service
1-(800)-259-5361
Customerservice@icumed.com
Media:
Harrison Richards
949-366-4261
Harrison.Richards@icumed.com
Back to Top